Belite Bio, Inc (BLTE) Q3 Net Loss Widens To $30.3M
Belite Bio reported a Q3 2026 net loss of $30.3M, compared with $21.7M in Q3 2025. Cash and cash equivalents were $271.3M at September 30, 2026, versus $352.9M at December 31, 2025.Material DetailsContext by AI AnalystThis is a financial update ahead of the expected February 12, 2027 PDUFA target a…